Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
Alzheimer's disease |
N/A |
N/A |
N/A |
expression |
We selected three differential signature genes specific for the early stage (Nudt19, Arl16, Aph1b), five common to both groups (Slc15a2, Agpat5, Sox2ot, 2210015, D19Rik, Wdfy1), and seven specific for late stage (D14Ertd449, Tia1, Txnl4, 1810014B01Rik). |
21961160 |
LncRNADisease
|
Neurodevelopmental syndromes associated with the SOX2 locus |
N/A |
N/A |
N/A |
regulation |
Genomic context links lncRNAs to disease genes/loci and related pathways |
23791884 |
LncRNADisease
|
esophageal squamous cell carcinoma |
N/A |
N/A |
N/A |
expression |
The results revealed a significant co-upregulation of SOX2OT along with SOX2 and OCT4 in tumor samples, compared to the non-tumor tissues obtained from the margin of same tumors. Therefore, the SOX2 gene might be a indicator for the early diagnosis of ESCC. |
24817925 |
LncRNADisease
|
esophageal squamous cell carcinoma |
qPCR, knockdown etc. |
ESCC tissue, cell lines (NT2, U-87 MG etc.) |
up-regulated |
N/A |
Our data revealed a high level of SOX2OT expression in tumor samples of ESCC, compared to that of apparently normal marginal tissues obtained from the same patients (P<0.01). All together, our data provide a novel regulatory mechanism governing the key stem cell pluripotency genes, SOX2 and OCT4, mediated by the lncRNA SOX2OT. |
24105929 |
Lnc2Cancer
|
hepatocelluar carcinoma |
qPCR, knockdown etc. |
HCC tissue, cell lines (HepG2, SMMC-7721) |
up-regulated |
expression |
lncRNA Sox2ot expression level was significantly higher in HCC tissues compared with adjacent non-tumor tissues. High expression of lncRNA Sox2ot was associated with histological grade, TNM stage, and vein invasion. |
26097588 |
Lnc2Cancer
|
breast cancer |
qPCR, Western blot etc. |
cell lines (MCF10A) |
up-regulated |
N/A |
The expression of SOX2 and SOX2OT is concordant in breast cancer, differentially expressed in estrogen receptor positive and negative breast cancer samples and that both are up-regulated in suspension culture conditions that favor growth of stem cell phenotypes. Importantly, ectopic expression of SOX2OT led to an almost 20-fold increase in SOX2 expression, together with a reduced proliferation and increased breast cancer cell anchorage-independent growth. |
25006803 |
Lnc2Cancer
|
lung squamous cell carcinoma |
qPCR, Western blot, knockdown, RIP etc. |
cell lines (A549, HCC827, SK-MES-1, NCI-H1299 etc.) |
up-regulated |
N/A |
Sox2ot exprssion in lung cancer is significantly higher and promotes cancer cell proliferation. Sox2ot plays an important role in regulating lung cancer cell proliferation, and may represent a novel prognostic indicator for the disease. |
24927902 |
Lnc2Cancer
|
non-small cell lung cancer |
real-time quantitative reverse transcription PCR (qRT-PCR) |
lung tumor tissues |
up-regulated |
N/A |
SOX2OT knockdown significantly reduced the colony formation ability of cancer cells |
26846097 |
|
|